These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2193707)

  • 1. Haemophilus influenzae: surface antigens and aspects of virulence.
    Munson RS
    Can J Vet Res; 1990 Apr; 54 Suppl():S63-7. PubMed ID: 2193707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects for the vaccinal prevention of Haemophilus influenzae type b meningitis].
    Armand J
    Pathol Biol (Paris); 1983 Feb; 31(2):144-8. PubMed ID: 6341945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.
    Weinberg GA; Granoff DM; Nahm MH; Shackelford PG
    J Immunol; 1986 Jun; 136(11):4232-6. PubMed ID: 3486228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.
    Ribeiro GS; Reis JN; Cordeiro SM; Lima JB; Gouveia EL; Petersen M; Salgado K; Silva HR; Zanella RC; Almeida SC; Brandileone MC; Reis MG; Ko AI
    J Infect Dis; 2003 Jan; 187(1):109-16. PubMed ID: 12508153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemophilus influenzae type B. Disease and prevention].
    Stehr K
    Monatsschr Kinderheilkd; 1990 May; 138(5):240-3. PubMed ID: 2198458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A; Riesbeck K; Janson H
    Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccines against Haemophilus influenzae B: present, past and future].
    Gómez de León-Cruces P; Cabrera-Contreras R
    Salud Publica Mex; 1992; 34(3):274-86. PubMed ID: 1615346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
    Shenep JL; Munson RS; Barenkamp SJ; Granoff DM
    Infect Immun; 1983 Oct; 42(1):257-63. PubMed ID: 6604698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
    Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
    Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsules and virulence in the HAP group of bacteria.
    Inzana TJ
    Can J Vet Res; 1990 Apr; 54 Suppl():S22-7. PubMed ID: 2193699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae and the complement system.
    Hallström T; Riesbeck K
    Trends Microbiol; 2010 Jun; 18(6):258-65. PubMed ID: 20399102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.
    Moxon ER; Kroll JS
    Vaccine; 1988 Apr; 6(2):113-5. PubMed ID: 3291448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections.
    Claesson BA; Lagergård T; Trollfors B; Gothefors L; Jodal U
    J Clin Microbiol; 1987 Dec; 25(12):2339-43. PubMed ID: 3501433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B.
    Anderson P
    J Immunol; 1978 Mar; 120(3):866-70. PubMed ID: 75930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.